ARQT · Arcutis Biotherapeutics, Inc. · Executive Compensation
$28.26
+0.73 (+2.65%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$3.57B
Shares
126.46M
Volume · Nov 13
858.23K
Avg daily vol (3M)
2.62M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Todd Franklin Watanabe | President and Chief Executive Officer | $7,223,065 |
| L. Todd Edwards | Chief Commercial Officer | $3,030,337 |
| Patrick Burnett | M.D., Ph.D. Chief Medical Officer | $3,016,508 |
| Masaru Matsuda | Chief Legal Officer | $2,118,203 |
| David Topper | Former Chief Financial Officer | $1,946,733 |
| Latha Vairavan | Chief Financial Officer | $1,924,780 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| David Topper | Chief Financial Officer | $5,311,203 |
| Todd Franklin Watanabe | President and Chief Executive Officer | $3,689,491 |
| Patrick Burnett | M.D., Ph.D. Chief Medical Officer | $2,513,050 |
| John Smither | Chief Financial Officer | $2,102,418 |
| L. Todd Edwards | Chief Commercial Officer | $1,965,145 |
| Masaru Matsuda | General Counsel | $1,737,532 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Todd Franklin Watanabe | President and Chief Executive Officer | $4,935,266 |
| Patrick Burnett | M.D., Ph.D. Chief Medical Officer | $1,666,345 |
| L. Todd Edwards | Chief Commercial Officer | $1,657,847 |
| Masaru Matsuda | General Counsel | $1,603,149 |
| General Counsel | — | $1,603,149 |
| John Smither | Chief Financial Officer | $1,036,225 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| General Counsel | — | $5,142,764 |
| Masaru Matsuda | General Counsel | $5,142,764 |
| Todd Franklin Watanabe | President and Chief Executive Officer | $4,581,555 |
| Patrick Burnett | M.D., Ph.D. Chief Medical Officer | $1,584,078 |
| Kenneth Lock | Chief Commercial Officer | $1,270,018 |
| Scott Burrows | Chief Financial Officer | $1,246,136 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John Smither | Chief Financial Officer | $6,250,292 |
| Todd Franklin Watanabe | President and Chief Executive Officer | $4,284,123 |
| Matthew R. Moore | Chief Business Officer | $3,794,104 |
| Scott Burrows | Chief Financial Officer | $2,080,377 |
| Patrick Burnett | M.D., Ph.D. Chief Medical Officer | $1,671,128 |
| Kenneth Lock | Chief Commercial Officer | $1,564,381 |
| David W. Osborne | Chief Technical Officer | $1,555,578 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Patrick Burnett | M.D., Ph.D. Chief Medical Officer | $6,849,038 |
| Todd Franklin Watanabe | President and Chief Executive Officer | $2,750,883 |
| Kenneth Lock | Chief Commercial Officer | $1,267,692 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Todd Franklin Watanabe | President and Chief Executive Officer | $1,140,296 |
| Kenneth Lock | Chief Commercial Officer | $766,075 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Rob Scott, MD | Arcutis Board of Directors | Appointed | 2026-10-28 |
| Chris Peetz | Board of Directors | Appointed | 2026-08-05 |
| Christopher Peetz | Class III director | Appointed | 2026-07-16 |
| Amit D. Munshi | chair of the Compensation Committee of the Board | Appointed | 2025-12-08 |
| Amit D. Munshi | new Class II director | Appointed | 2025-12-08 |
| Bhaskar Chaudhuri | chair of the Compensation Committee of the Board | Retired | 2025-12-08 |
| Bhaskar Chaudhuri | member of the Board of Directors | Retired | 2025-12-08 |
| Latha Vairavan | Chief Financial Officer (CFO) | Appointed | 2025-04-10 |
| David Topper | Chief Financial Officer | Retired | 2025-04-10 |
| David Topper | principal accounting officer | Appointed | 2024-04-10 |
| David Topper | Chief Financial Officer | Appointed | 2024-04-10 |
| L. Todd Edwards | Chief Commercial Officer | Appointed | 2023-09-27 |
| John Smither | interim chief financial officer | Appointed | 2023-08-18 |
| Scott Burrows | chief financial officer | Resigned | 2023-08-18 |
| Ayisha Jeter | interim chief commercial officer | Appointed | 2023-05-24 |
| Kenneth Lock | Senior Vice President and Chief Commercial Officer | Resigned | 2023-05-24 |
| Neha Krishnamohan | Class III director and member of the Audit Committee | Appointed | 2022-09-06 |
Leadership
- Todd Franklin Watanabe CEO, Board Member
- Latha Vairavan CFO
- Masaru Matsuda General Counsel
- David Topper Chief Accounting Officer
- Scott Burrows Chief Accounting Officer
- Amit D. Munshi Board Member
- Chris Peetz Board Member
- Christopher Peetz Board Member
- Halley E. Gilbert Board Member
- Howard G. Welgus Board Member
- Howard Welgus, M.D., FAAD Board Member
- Keith R. Leonard Board Member
- Keith R. Leonard Jr. Board Member
- Neha Krishnamohan Board Member
- Patrick J. Heron Board Member
- Rob Scott, MD Board Member
- Sue-Jean Lin Board Member
- Terrie Curran Board Member
Key facts
CIK
1787306
CUSIP
03969K108
13F (30d)
222 filings
200 filers
Visit website
Investor relations